Oliver Lagore Vanvalin Investment Group’s Thermo Fisher Scientific TMO Stock Holding History

Oliver Lagore Vanvalin Investment Group’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$25.4K	Buy	+51	New	+$21.3K	0.01%	319
2024 Q4	$26.5K	Hold	51	–	–	0.01%	324
2024 Q3	$31.5K	Hold	51	–	–	0.01%	294
2024 Q2	$28.2K	Sell	51 -6	-11%	-$3.44K	0.01%	301
2024 Q1	$33.1K	Sell	57 -4	-7%	-$2.25K	0.01%	283
2023 Q4	$32.4K	Hold	61	–	–	0.01%	257
2023 Q3	$30.9K	Buy	61 +1	+2%	+$533	0.01%	289
2023 Q2	$31.3K	Sell	60 -11	-15%	-$5.94K	0.01%	310
2023 Q1	$40.9K	Hold	71	–	–	0.02%	209
2022 Q4	$39.1K	Sell	71 -1	-1%	-$530	0.02%	203
2022 Q3	$37K	Buy	72 +8	+13%	+$4.48K	0.02%	192
2022 Q2	$35K	Hold	64	–	–	0.02%	212
2022 Q1	$38K	Buy	+64	New	+$36.8K	0.03%	198

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Oliver Lagore Vanvalin Investment Group's TMO Position: Q2 2025 in Review

Oliver Lagore Vanvalin Investment Group opened a new position in Thermo Fisher Scientific (TMO) in Q2 2025: 51 shares worth $25.4K. The stake represents 0.01% of the portfolio and ranks #319 among its holdings. This is a return to the name: Oliver Lagore Vanvalin Investment Group previously reported a position in TMO as recently as Q4 2024.

Oliver Lagore Vanvalin Investment Group first reported a position in TMO in Q1 2022 and has held it in 13 quarters since. The position peaked at $40.9K in Q1 2023. 2,454 funds tracked by Wall St. Rank hold TMO as of Q2 2025.

Oliver Lagore Vanvalin Investment Group held 51 shares of Thermo Fisher Scientific worth $25.4K as of Q2 2025.
Thermo Fisher Scientific was a new Oliver Lagore Vanvalin Investment Group position in Q2 2025.
Thermo Fisher Scientific made up 0.01% of Oliver Lagore Vanvalin Investment Group's portfolio in Q2 2025, its #319 holding.
Oliver Lagore Vanvalin Investment Group first reported a position in Thermo Fisher Scientific in Q1 2022 and has held it in 13 quarters since.
Oliver Lagore Vanvalin Investment Group's Thermo Fisher Scientific position peaked at $40.9K in Q1 2023.
2,454 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2025.

Based on Oliver Lagore Vanvalin Investment Group's 13F filing for Q2 2025, filed 10 Jul 2025.